| Location: | District of Columbia |
|---|---|
| Posted: | Sep 25, 2025 |
| Due: | Dec 19, 2025 |
| Agency: | HEALTH AND HUMAN SERVICES, DEPARTMENT OF |
| Type of Government: | Federal |
| Category: |
|
| Solicitation No: | ARPA-H-SOL-25-122 |
| Publication URL: | To access bid details, please log in. |
APEX Accelerators are an official government contracting resource for small businesses. Find your local APEX Accelerator (opens in new window) for free government expertise related to contract opportunities.
APEX Accelerators are funded in part through a cooperative agreement with the Department of Defense.
The APEX Accelerators program was formerly known as the Procurement Technical Assistance Program (opens in new window) (PTAP).
The Advanced Research Projects Agency for Health (ARPA-H) Treating Hereditary Rare diseases with In Vivo precision genetic mEdicines (THRIVE) program envisions a future where patients can opt for one-time therapeutic interventions designed to slow, reverse, or cure disease, harnessing revolutionary technologies and a rapidly evolving understanding of the genetic underpinnings of the biological processes that lead to disease.
Interested parties are invited to review the attached THRIVE Innovative Solutions Opening (ISO) ARPA-H -SOL-25-122.
For detailed information regarding Proposers' Day review Special Notice (SN) ARPA-H-SN-25-131.
Solution summaries are due October 31, 2025, 11:59 PM ET.
For more information about THRIVE, please visit:https://arpa-h.gov/explore-funding/programs/thrive
| Oct 9, 2025 | [Solicitation (Updated)] Treating Hereditary Rare Diseases With In Vivo Precision Genetic Medicines (THRIVE) |
| Oct 17, 2025 | [Solicitation (Updated)] Treating Hereditary Rare Diseases With In Vivo Precision Genetic Medicines (THRIVE) |
| Oct 27, 2025 | [Solicitation (Updated)] Treating Hereditary Rare Diseases With In Vivo Precision Genetic Medicines (THRIVE) |
| Nov 15, 2025 | [Solicitation (Updated)] Treating Hereditary Rare Diseases With In Vivo Precision Genetic Medicines (THRIVE) |
| Dec 2, 2025 | [Solicitation (Updated)] Treating Hereditary Rare Diseases With In Vivo Precision Genetic Medicines (THRIVE) |
| Dec 15, 2025 | [Solicitation (Updated)] Treating Hereditary Rare Diseases With In Vivo Precision Genetic Medicines (THRIVE) |
| Jan 9, 2026 | [Solicitation (Updated)] Treating Hereditary Rare Diseases With In Vivo Precision Genetic Medicines (THRIVE) |

With GovernmentContracts, you can:
Status OPEN Solicitation Number Doc827769 Title DC Health Open Platform HALT Application Agency
District of Columbia
Bid Due: 6/08/2026
Follow OPM Integrated Security Maintenance Systems Maintenance & Repair Active Contract Opportunity Notice
OFFICE OF PERSONNEL MANAGEMENT
Bid Due: 6/05/2026
Follow Legal Support Services Active Contract Opportunity Notice ID FRTIB1-26-Q-0020 Related Notice Department/Ind.
FEDERAL RETIREMENT THRIFT INVESTMENT BOARD
Bid Due: 6/29/2026
Follow Purchase Array Detector Active Contract Opportunity Notice ID N0017326P1301365564 Related Notice Department/Ind.
DEPT OF DEFENSE
Bid Due: 6/04/2026